• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Newsletters » The Carlat Addiction Treatment Report
carlat-addiction-header.png

The Carlat Addiction Treatment Report

Stimulant Abuse (September/October) | 2014

View Archived Issues

Alcohol Responsible for 10% of Adult Deaths in US

A new report from the Centers for Disease Control and Prevention (CDC) says that in adults ages 20 to 64, one in 10 deaths are the result of excessive drinking. Read More

Cognitive Enhancers: Smart Drugs or Bad Idea?

Today’s conversation about “smart drugs” is fundamentally different and refers to the use of medications by people without psychiatric disorders who seek a boost or cognitive edge. Read More

Deconstructing Red Bull

Americans guzzled a mind-blowing 3.5 billion energy drinks in 2013, with sales totaling $8.7 billion. But what, exactly, are energy drinks? Do they actually give you energy? And are they safe? Read More

Malingered ADHD

Get insight into the problem of malingering—in other words faking—ADHD symptoms by patients who may want to receive academic accommodations or obtain prescription stimulants, in an interview with researcher Mandi Musso, PhD. Read More

Substance Abuse Treatment for Individuals with Traumatic Brain Injury

Learn some of the key best practices that can help you work with patients in substance abuse treatment who also have a traumatic brain injury, in an interview with Duane Reynolds, LSW, LADC, associate director of the Vinland National Center in Minnesota. Read More

Evaluating and Treating ADHD Symptoms in Patients with Addiction

Find out more about how you can evaluate and treat ADHD symptoms in patients with addiction, in an interview with clinical neuropsychologist Christopher B. Mertz. Read More

Buprenorphine Reduces Total Cost of Care

Buprenorphine (Suboxone and others) is an effective medication for treating patients with opioid addiction. Research has shown that it works better than standard psychosocial or “abstinence-based” treatments. But is the cost of the drug worth the extra therapeutic benefit? Read More

More Questions Than Answers About New Addiction

New technology has brought with it a new addiction. Clinicians may now face the challenge of how to treat the growing problem of internet addiction, where patients experience online-related, compulsive behaviors that interfere with daily life, work, and relationships. Read More

Two Old Drugs Made New

Naltrexone, which first hit the US market in 1984 as a treatment for alcohol dependence, continues to find new uses. Its latest incarnation, Contrave, was just approved by the Food and Drug Administration (FDA) in September as a weight loss medication. Read More

Learning Objectives, Stimulant Abuse, CATR, September/October 2014

After reading these articles, you should be able to… Read More
SUBSCRIBE NOW
Editor-in-Chief
NCapurso.png
Noah Capurso, MD, MHS,

Dr. Capurso is an assistant professor of psychiatry at the Yale University School of Medicine and practices clinically at the West Haven Veterans Administration Hospital. He attended medical school at Yale, where he received his MD, and where he conducted research in the Department of Biomedical Engineering. He stayed at Yale for residency and addiction psychiatry fellowship training. As an educator, Dr. Capurso teaches medical students about addiction treatment and develops the psychiatric curriculum for residents. As a clinician, Dr. Capurso is the medical director of the VA’s Detoxification & Addiction Stabilization Service and the Psychosocial Residential Rehabilitation Program.

Full Editorial Information
Featured Book
  • PracticeBoosters2e.JPG

    Psychiatry Practice Boosters, Second Edition (2018)

    Teaches you the key points of 42 of the most clinically relevant studies in psychiatry published...
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • Substance_Use_Sites.jpeg
    Addiction Treatment

    Supervised Drug Consumption Sites

    Once controversial, research clearly shows the benefit of these sites, and they have started opening in the United States.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.